Orexigen Therapeutics, Inc. 4
4 · Orexigen Therapeutics, Inc. · Filed Jun 2, 2017
Insider Transaction Report
Form 4
NARACHI MICHAEL
DirectorPresident and CEO
Transactions
- Award
Common Stock
2017-05-31$1.55/sh+626$970→ 8,356 total
Footnotes (1)
- [F1]Shares acquired under Issuer's 2013 Employee Stock Purchase Plan.